The BCR-ABL tyrosine kinase (TK) formed by the balanced translocation t(9;22)(q34;q11) is the key player in the pathogenesis of chronic myeloid leukemia (CML). This evidence concerns the gene TKT and chronic myelogenous leukemia, BCR-ABL1 positive.